{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:10:35Z","timestamp":1781975435752,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40199-021-00425-5","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:04:02Z","timestamp":1642032242000},"page":"159-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Probable ertapenem-induced encephalopathy; case report and suggested alternatives for chronic prostatitis"],"prefix":"10.1007","volume":"30","author":[{"given":"Beatriz","family":"Fern\u00e1ndez-Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Luque-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Victoria","family":"Gil-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"425_CR1","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1128\/AAC.05913-11","volume":"56","author":"VL Collins","year":"2012","unstructured":"Collins VL, Marchaim D, Pogue JM, Moshos J, Bheemreddy S, Sunkara B, et al. Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-\u03b2-lactamase-producing enterobacteriaceae. Antimicrob Agents Chemother. 2012;56:2173\u20137. https:\/\/doi.org\/10.1128\/AAC.05913-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1592\/phco.31.4.408","volume":"31","author":"AD Miller","year":"2011","unstructured":"Miller AD, Ball AM, Bookstaver PB, Dornblaser EK, Bennett CL. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. 2011;31:408\u201323. https:\/\/doi.org\/10.1592\/phco.31.4.408.","journal-title":"Pharmacotherapy"},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10096-005-0021-y","volume":"24","author":"KM Chow","year":"2005","unstructured":"Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis. 2005;24:649\u201353. https:\/\/doi.org\/10.1007\/s10096-005-0021-y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"425_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.seizure.2020.08.012","volume":"81","author":"P Wanleenuwat","year":"2020","unstructured":"Wanleenuwat P, Suntharampillai N, Iwanowski P. Antibiotic-induced epileptic seizures: mechanisms of action and clinical considerations. Seizure. 2020;81:167\u201374. https:\/\/doi.org\/10.1016\/j.seizure.2020.08.012.","journal-title":"Seizure"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ijantimicag.2009.06.001","volume":"34","author":"F Lamoth","year":"2009","unstructured":"Lamoth F, Erard V, Asner S, Buclin T, Calandra T, Marchetti O. High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction. Int J Antimicrob Agents. 2009;34:386\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.06.001.","journal-title":"Int J Antimicrob Agents"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/jac\/dkl354","volume":"58","author":"AC Rodloff","year":"2006","unstructured":"Rodloff AC, Goldstein EJC, Torres A. Two decades of imipenem therapy. J Antimicrob Chemother. 2006;58:916\u201329. https:\/\/doi.org\/10.1093\/jac\/dkl354.","journal-title":"J Antimicrob Chemother"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11096-013-9812-x","volume":"35","author":"Y Shea","year":"2013","unstructured":"Shea Y, Mok MM, Cheng K, Hon FS, Chu L. Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism. Int J Clin Pharm. 2013;35:535\u20137. https:\/\/doi.org\/10.1007\/s11096-013-9812-x.","journal-title":"Int J Clin Pharm"},{"key":"425_CR8","doi-asserted-by":"publisher","first-page":"232470961668937","DOI":"10.1177\/2324709616689376","volume":"5","author":"SS Sutton","year":"2017","unstructured":"Sutton SS, Jumper M, Cook S, Edun B, Wyatt MD. Ertapenem-induced encephalopathy in a patient with normal renal function. J Investig Med High Impact Case Rep. 2017;5:2324709616689376. https:\/\/doi.org\/10.1177\/2324709616689376.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"425_CR9","doi-asserted-by":"publisher","unstructured":"Hsaiky LM, Salinitri FD, Wong J, Jennings S-LT, Desai NH, Lobkovich AM, et al. Pharmacokinetics and investigation of optimal dose ertapenem in intermittent hemodialysis patients. Nephrol Dial Transplant 2019 1;34:1766\u201372. https:\/\/doi.org\/10.1093\/ndt\/gfy166","DOI":"10.1093\/ndt\/gfy166"},{"key":"425_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182046","volume":"12","author":"Y-C Lee","year":"2017","unstructured":"Lee Y-C, Huang Y-J, Hung M-C, Hung S-C, Hsiao C-Y, Cho H-L, et al. Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control study. PLoS ONE. 2017;12: e0182046. https:\/\/doi.org\/10.1371\/journal.pone.0182046.","journal-title":"PLoS ONE"},{"key":"425_CR11","doi-asserted-by":"publisher","unstructured":"Dan\u00e9s I, P\u00e9rez E, Pigrau C, Gracia RM, Perell\u00f3 M, Sueiras M, et al. A case series of confusional states and other neurotoxic effects caused by ertapenem. Br J Clin Pharmacol 2020 3; https:\/\/doi.org\/10.1111\/bcp.14582","DOI":"10.1111\/bcp.14582"},{"key":"425_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bcr-2019-231875","volume":"1","author":"R Adams","year":"2020","unstructured":"Adams R, Chopra P, Miranda R, Calderon A. Ertapenem-induced encephalopathy. BMJ Case Rep. 2020;1:13. https:\/\/doi.org\/10.1136\/bcr-2019-231875.","journal-title":"BMJ Case Rep"},{"issue":"45","key":"425_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/45.1.5","volume":"1","author":"SR Norrby","year":"2000","unstructured":"Norrby SR. Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis. J Antimicrob Chemother. 2000;1(45):5\u20137. https:\/\/doi.org\/10.1093\/jac\/45.1.5.","journal-title":"J Antimicrob Chemother"},{"issue":"73","key":"425_CR14","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.2146\/ajhp150201","volume":"1","author":"EK Chung","year":"2016","unstructured":"Chung EK, Beeler CB, Muloma EW, Osterholzer D, Damer KM, Erdman SM. Development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy program. Am J Health Syst Pharm. 2016;1(73):e24-33. https:\/\/doi.org\/10.2146\/ajhp150201.","journal-title":"Am J Health Syst Pharm"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11096-018-0694-9","volume":"40","author":"SK Behera","year":"2018","unstructured":"Behera SK, Das S, Xavier AS, Velupula S, Sandhiya S. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm. 2018;40:903\u201310. https:\/\/doi.org\/10.1007\/s11096-018-0694-9.","journal-title":"Int J Clin Pharm"},{"key":"425_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1179\/1973947814Y.0000000179","volume":"27","author":"S Munoz-Gomez","year":"2015","unstructured":"Munoz-Gomez S, Gran A, Cunha BA. Meropenem delirium: a previously unrecognized neurologic side effect. J Chemother. 2015;27:120\u20131. https:\/\/doi.org\/10.1179\/1973947814Y.0000000179.","journal-title":"J Chemother"},{"issue":"72","key":"425_CR17","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/jac\/dkx209","volume":"1","author":"S Imani","year":"2017","unstructured":"Imani S, Buscher H, Marriott D, Gentili S, Sandaradura I. Too much of a good thing: a retrospective study of \u03b2-lactam concentration\u2013toxicity relationships. J Antimicrob Chemother. 2017;1(72):2891\u20137. https:\/\/doi.org\/10.1093\/jac\/dkx209.","journal-title":"J Antimicrob Chemother"},{"key":"425_CR18","first-page":"497","volume":"81","author":"M Beumier","year":"2015","unstructured":"Beumier M, Casu GS, Hites M, Wolff F, Cotton F, Vincent JL, et al. Elevated \u03b2-lactam concentrations associated with neurological deterioration in ICU septic patients. Minerva Anestesiol. 2015;81:497\u2013506.","journal-title":"Minerva Anestesiol"},{"issue":"23","key":"425_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/neuonc\/noaa183","volume":"30","author":"NG Holtzman","year":"2021","unstructured":"Holtzman NG, Xie H, Bentzen S, Kesari V, Bukhari A, El Chaer F, et al. Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes. Neuro Oncol. 2021;30(23):112\u201321. https:\/\/doi.org\/10.1093\/neuonc\/noaa183.","journal-title":"Neuro Oncol"},{"key":"425_CR20","doi-asserted-by":"publisher","unstructured":"Saito J, Shoji K, Oho Y, Kato H, Matsumoto S, Aoki S, et al. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients. Antimicrob Agents Chemother [Internet] 2021 20 [cited 2021 18];65. https:\/\/doi.org\/10.1128\/AAC.01909-20","DOI":"10.1128\/AAC.01909-20"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-021-00425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-021-00425-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-021-00425-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:57:49Z","timestamp":1652799469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-021-00425-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s40199-021-00425-5","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applied.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor of this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}